ArticleScientific reports2025
Predictive model of ulcerative colitis syndrome with ensemble learning and interpretability methods.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
In recent years, the prevalence of chronic diseases such as Ulcerative Colitis (UC) has increased, bringing a heavy burden to healthcare systems. Traditional Chinese Medicine (TCM) stands out for its cost-effective and efficient treatment modalities, providing unique advantages in healthcare. But syndrome differentiation of UC presents a longstanding challenge in TCM due to its chronic nature and varied manifestations. While existing research has primarily explored machine learning applications for diagnosis and prognosis prediction, the critical issue of explainability in syndrome differentiation remains underexamined. To bridge this gap, we propose an ensemble prediction model enhanced with SHAP (SHapley Additive exPlanations) and LIME (Local Interpretable Model-agnostic Explanations) to improve interpretability and clinical utility. Our study utilizes a dataset of 8078 electronic medical records from Dongfang Hospital, Beijing University of Chinese Medicine, collected between 2006 and 2019. Comprehensive evaluations demonstrate that our ensemble models outperform individual deep learning approaches, with the Gradient Boosting (GB) model achieving 83% F1 in syndrome differentiation. Furthermore, SHAP and LIME reveal key features associated with different syndromes, such as frequent stool in spleen-kidney yang deficiency and lower abdominal coldness in spleen yang deficiency, offering valuable insights for intelligent syndrome differentiation. These findings hold significant promise for advancing TCM-based UC management, enhancing clinical decision-making, and improving patient outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.